BMC Neurol

1. CARDONA-ROCA L, Segui-Solanes C, Cano-Alonso M, Sosa-Pons A, et al
   Impact of anti-CGRP monoclonal antibodies on treatment satisfaction and quality of life in patients with resistant migraine: a retrospective real-world study.
   BMC Neurol. 2025;25:418.
   

   >> Share

   
   

   
   Cephalalgia

2. TAMAYO DE LEON CD, Gama-Reyes EG, Paredes Moreno FA, Galnares-Olalde JA, et al
   Adjunctive occipital nerve block for emergency treatment of acute migraine: A randomized, controlled trial.
   Cephalalgia. 2025;45:3331024251381764.
   

   >> Share

   
   
3. YU S, Matsumori Y, Kim BK, Gryglas-Dworak A, et al
   Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial.
   Cephalalgia. 2025;45:3331024251386095.
   

   >> Share

   
   
4. POZO-ROSICH P, Blumenfeld AM, Lipton RB, DeGryse RE, et al
   OnabotulinumtoxinA for the preventive treatment of episodic migraine: Results from the phase 3, multicenter randomized, double-blind, placebo-controlled phase of the PRECLUDE trial.
   Cephalalgia. 2025;45:3331024251370769.
   

   >> Share

   
   

   
   Headache

5. QAISER S, Shady K
   Serum magnesium levels in children and adolescents with migraine: A prospective observational study.
   Headache. 2025 Oct 16. doi: 10.1111/head.15081.
   

   >> Share

   
   
6. NAHAS SJ, Birlea M, Stark-Inbar A, Shmuely S, et al
   Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon.
   Headache. 2025 Oct 16. doi: 10.1111/head.15069.
   

   >> Share

   
   
7. GRODZKA O, Boronczyk M, Zdunska A, Wegrzynek-Gallina J, et al
   Migraine and patent foramen ovale: correlation, coexistence, dependence. A narrative review.
   Headache. 2025 Oct 15. doi: 10.1111/head.15067.
   

   >> Share

   
   
8. PERIS-SUBIZA J, Obach V, Guisado-Alonso D, Velasco Juanes F, et al
   Effectiveness and tolerability of galcanezumab for migraine prevention in patients >/=65 years: A real-life multicenter study.
   Headache. 2025 Oct 14. doi: 10.1111/head.15064.
   

   >> Share

   
   
9. OGREZEANU DC, Nunez-Cortes R, Salazar-Mendez J, Cuyul-Vasquez I, et al
   How much aerobic exercise is needed to reduce migraine? A dose-response meta-analysis of pain intensity and frequency.
   Headache. 2025 Oct 14. doi: 10.1111/head.15070.
   

   >> Share

   
   
10. PAIVA DA SILVA LIMA G, Rao R, Szabo G, Szklener S, et al
    Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study.
    Headache. 2025 Oct 14. doi: 10.1111/head.15071.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

11. GOUFA E, Chentouf A, Belabbas S, Boughrara W, et al
    Impact of fasting during Ramadan on migraine in the Algerian population.
    Neurologia (Engl Ed). 2025;40:762-767.
    

    >> Share

    
    

    
    Neurology

12. TU YH, Huang TC, Tzeng YS, Chen SP, et al
    Prevalence, Clinical Correlates, and Functional Implications of Vestibular Symptoms in Patients With Migraine.
    Neurology. 2025;105:e214248.
    

    >> Share

    
    
13. JANG SI, Kim N, Han K, Lee MJ, et al
    Association Between Obesity and the Risk of Migraine: A Nationwide Cohort Study in South Korea.
    Neurology. 2025;105:e214252.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share